Fingerprint
Dive into the research topics of 'Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of TAK-442, an oral factor Xa inhibitor, in patients following acute coronary syndrome
Sidney Goldstein, Eric R. Bates, Deepak L. Bhatt, Charlie Cao, David Holmes, Stuart Kupfer, Felipe Martinez, Jeffrey Spaeder, Jeffrey I. Weitz, Zhan Ye, Faiez Zannad
Research output: Contribution to journal › Article › peer-review
26
Scopus
citations